FDA Inspection 1202263 — Phillip C. Williamson, Ph.D.
The FDA completed an inspection of Phillip C. Williamson, Ph.D. on April 6, 2023 in Tempe, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 6, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Tempe, AZ (United States)
Additional Details
Clinical Investigator (CI)